A specific epigenetic signature in patients who respond to chemotherapy offers potential to improve treatment.
A long-lasting drug delivery system to treat HIV
This clever drug delivery platform could improve HIV patients’ adherence to treatment and help eradicate the virus.
Super seaweed from sustainable aquaculture
A new cultivation method enhances the concentration of valuable compounds in seaweeds with substantial environmental benefits.
Influenza vaccine turns the virus on its head
To create a flu vaccine that doesn’t require annual tweaking, researchers develop a nanovaccine that uses an inverted hemagglutinin protein.
Decoy particles trick SARS-CoV-2
Using nanoparticles fitted with ACE2 receptors, researchers hope to lure SARS-CoV-2 away from healthy cells to inhibit the virus and treat infection.
Antibodies active against SARS-CoV-2 found in 20-year-old library
Three potent antibodies against SARS-CoV-2 identified in healthy individuals decades ago raises interesting questions about their origins and evolution.
Pioneers in Science: Kitasato Shibasaburō
A pioneer in preventative medicine well known for his isolation of the bacteria behind the bubonic plague, Shibasaburō helped establish our understanding of infectious diseases and made inroads into the first vaccines.
Graphene adjuvant improves efficacy of dendritic cell vaccines
Dendritic cell vaccines offer a unique opportunity in biomedicine, and limitations in efficacy can now potentially be overcome using graphene oxide nanosheets.
Is “synonymous recoding” the future of vaccine development?
Large-scale recoding of virus genomes has the potential for use in vaccine design.
Metabolic activators improve recovery time in patients with mild to moderate COVID-19
Small clinical trial has found that metabolic activators can improve recovery, liver health, and markers of inflammation in patients with COVID-19.